P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma

• Harsh Shah,
• Victoria Vardell,
• Erin Zacholski,
• Amanda Fegley,
• Kalub Fedak,
• Suchitra Sundaram,
• Sridevi Rajeeve,
• Gaurav Goyal,
• Haris Hatic,
• Pallawi Torka,
• Sheeba Ba Aqeel,
• Azra Borogovac,
• Kira Macdougall,
• Shalin Kothari,
• Anna Kress,
• Dipenkumar Modi,
• Elizabeth Travers,
• Nitin Chilakamarri,
• Elizabeth Brem,
• Deborah M. Stephens,
• Boyu Hu,
• Lindsey Fitzgerlad,
• Charlotte Wagner,
• Daniel Ermann

Affiliations

Harsh Shah

1 University of Utah

Victoria Vardell

1 University of Utah

Erin Zacholski

2 Virginia Commonwealth University

Amanda Fegley

2 Virginia Commonwealth University

Kalub Fedak

3 Karmanos Cancer Institute

Suchitra Sundaram

4 Tisch Cancer Institute

Sridevi Rajeeve

4 Tisch Cancer Institute

Gaurav Goyal

5 UAB

Haris Hatic

5 UAB

Pallawi Torka

6 Roswell Park Comprehensive Cancer Center

Sheeba Ba Aqeel

6 Roswell Park Comprehensive Cancer Center

Azra Borogovac

7 University of Oklahoma

Kira Macdougall

7 University of Oklahoma

Shalin Kothari

8 Yale Comprehensive Cancer Center

Anna Kress

8 Yale Comprehensive Cancer Center

Dipenkumar Modi

3 Karmanos Cancer Institute

Elizabeth Travers

9 University of Kentucky

Nitin Chilakamarri

10 University of California, Irvine

Elizabeth Brem

10 University of California, Irvine

Deborah M. Stephens

1 University of Utah

Boyu Hu

1 University of Utah

Lindsey Fitzgerlad

1 University of Utah

Charlotte Wagner

1 University of Utah

Daniel Ermann

1 University of Utah